CERTIFICATION
OF A FOREIGN PRIVATE ISSUER'S TERMINATION OF REGISTRATION OF A CLASS OF
SECURITIES UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ITS
TERMINATION OF THE DUTY TO FILE REPORTS UNDER SECTION 13(a) OR SECTION 15(d)
OF
THE SECURITIES EXCHANGE ACT OF 1934
(Address,
including zip code, and telephone number, including area code, of registrant's
principal executive offices)
Ordinary
shares, par value CHF 1 per share
American
Depositary Shares, each representing one half of one ordinary
share,
nominal
value CHF 1 per share
(Title
of
each class of securities covered by this Form)
Place
an
X in the appropriate box(es) to indicate the provision(s) relied upon to
terminate the duty to file reports under the Securities Exchange Act of
1934:
Rule
12h-6(a)
(for
equity
securities)
ü
Rule
12h-6(d)
(for
successor registrants)
□
Rule
12h-6(c)
(for
debt securities)
□
Rule
12h-6(i)
(for
prior Form 15 filers)
□
PART
I
Item
1. Exchange Act Reporting History
A. Ciba
Specialty Chemicals Holding Inc. (the “Company”) first incurred the duty
to file reports under Section 13(a) and Section 15(d) of the U.S. Securities
Exchange Act of 1934, as amended (the “Exchange Act”) in August 2000, when the
Company’s ADSs were listed on the New York Stock Exchange
(“NYSE”).
B. The
Company has filed or submitted all reports required under Exchange Act Section
13(a) and Section 15(d) and the corresponding Commission rules for the 12 months
preceding the filing of this form, and has filed at least one annual report
on
Form 20-F under Section 13(a).
Item
2. Recent United States Market Activity
The
Company has never sold its securities in the United States in a registered
offering under the U.S. Securities Act of 1933, as amended (“Securities
Act”).
Item
3. Foreign Listing and Primary Trading Market
A. The
Company’s ordinary shares, par value CHF 1 per share were traded on
the Swiss Exchange (SWX) in Zurich, Switzerland until June 25, 2001. Since
June 25, 2001, the Company’s ordinary shares are traded under the symbol “CIBN”
on virt-x Exchange Limited (“virt-x”), a cross-border trading platform for
European securities based in London, United Kingdom. The Company’s
ADSs, each representing one half of one ordinary share, nominal value CHF 1
per share, were listed on the NYSE in August 2000 and traded there under the
symbol “CSB”. The Company filed a Form 25 voluntarily applying for
delisting of the ADSs with the Commission on July 10, 2007.
B. The
Company’s ordinary shares were first listed and traded on the SWX on March 13,1997. The Company has maintained the listing on the SWX since such
initial listing.
C. The
percentage of trading in the ordinary shares on virt-x as of the 12-month period
beginning June 1, 2006 and ending on May 31, 2007 was 100%.
Item
4. Comparative Trading Volume Data
A. The
first date of the recent 12-month period used to meet the requirements of Rule
12h-6(a)(4)(i) is June 1, 2006, and the last date of such period if May 31,2007.
B. For
the same recent 12-month period, the average daily trading volume of the
ordinary shares and ADSs in the United States and on a worldwide basis for
the
period described in Item 4.A is set forth in the following table:
Average
Daily Trading Volume (in number of ordinary shares)
United
States (1)
7,899
Worldwide
498,540
(1)
In the United States our ordinary shares trade in the form of ADSs, each
of which represents one half of one ordinary share.
C.
The average daily trading volume of the ordinary shares and ADSs (expressed
in
terms of underlying ordinary shares) in the United States as a percentage of
the
average daily trading volume for such classes of securities on a worldwide
basis
was 1.56% for the period described in Item 4.A.
D. The
Company filed a Form 25 to voluntarily delist its ADSs with the Commission,
which became effective on July 20, 2007. As of this date, the average
daily trading volume of the ordinary shares and ADSs (expressed in terms of
underlying ordinary shares) in the United States as a percentage of the average
daily trading volume for such classes of securities on a worldwide basis for
the
preceding 12-month period, was 2.05%.
E. The
Company has not terminated a sponsored ADR facility for its ordinary
shares.
F. The
sources of the trading volume information is Bloomberg L.P.
Item
5. Alternative Record Holder Information
Not
applicable.
Item
6. Debt Securities
Not
applicable.
Item
7. Notice Requirement
A. The
notice required by Rule 12h-6(h), disclosing the Company’s intent to terminate
its duty to file reports under Section 13(a) of the Exchange Act, was published
on June 26, 2007.
B. To
disseminate such notice in the United States, a copy of the notice was filed
with the Commission under cover of a Form 6-K on June 26, 2007. The notice
was
distributed to the newswire services of Bloomberg, Reuters, Dow Jones, AFX
and
AWP.
Item
8. Prior Form 15 Filers
Not
applicable.
PART
II
Item
9. Rule 12g3-2(b) Exemption
The
Company’s Internet Web site on which it intends to publish the information
required under Rule 12g3-2(b)(1)(iii) is www.cibasc.com.
PART
III
Item
10. Exhibits
None.
Item
11. Undertakings
The
undersigned issuer hereby undertakes to withdraw this Form 15F if, at any time
before the effectiveness of its termination of reporting under Rule 12h-6,
it
has actual knowledge of information that causes it reasonably to believe that,
at the time of filing the Form 15F:
(1)
The
average daily trading volume of its subject class of securities in
the
United States exceeded 5 percent of the average daily trading volume
of
that class of securities on a worldwide basis for the same recent
12-month
period that the issuer used for purposes of Rule
12h-6(a)(4)(i);
(2)
Its
subject class of securities was held of record by 300 or more United
States residents or 300 or more persons worldwide, if proceeding
under
Rule 12h-6(a)(4)(ii) or Rule 12h-6(c);
or
(3)
It
otherwise did not qualify for termination of its Exchange Act reporting
obligations under Rule 12h-6.
Pursuant
to the requirements of the Securities Exchange Act of 1934, Ciba Specialty
Chemicals Holding Inc. has duly authorized the undersigned person to sign on
its
behalf this certification on Form 15F. In so doing, Ciba Specialty
Chemicals Holding Inc. certifies that, as represented on this Form, it has
complied with all of the conditions set forth in Rule 12h-6 for terminating
its
registration under Section 12(g) of the Exchange Act, or its duty to file
reports under Section 13(a) or Section 15(d) of the Exchange Act, or
both.
